Safety and feasibility of biweekly neoadjuvant gemcitabine, epirubicin, and albumin bound nab-paclitaxel (GEA) in locally advanced breast cancer – results of a phase II study
2008
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
1
Citations
NaN
KQI